Loading…
Modern Diagnostic & Research Centre (BSE 544673)₹55.00−0.88%Healthcare Service Provider
In the Mar 2026 quarter (standalone), Modern Diagnostic & Research Centre reported sales of ₹39.95 Cr and net profit of ₹2.09 Cr. For the year to Mar 2026, sales were ₹83.18 Cr and net profit ₹5.26 Cr.
Company filings, standalone accounts; latest reported quarter Mar 2026
| Mar 2026 | |
|---|---|
| Sales | 39.95 |
| Expenses | 34.82 |
| Operating Profit | 5.09 |
| OPM % | 12.7% |
| Other Income | 0.42 |
| Interest | 1.47 |
| Depreciation | 2.84 |
| Profit before tax | 1.19 |
| Tax % | −73.4% |
| Net Profit | 2.09 |
| EPS (Rs) | 1.39 |
| Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|
| Sales | 60.33 | 56.38 | 67.20 | 78.11 | 83.18 |
| Expenses | 54.17 | 57.20 | 55.95 | 59.92 | 70.48 |
| Operating Profit | 6.03 | −0.99 | 11.15 | 17.97 | 12.61 |
| OPM % | 10.0% | −1.8% | 16.6% | 23.0% | 15.1% |
| Other Income | 0.36 | 0.33 | 1.47 | 0.87 | 1.04 |
| Interest | 1.58 | 1.42 | 1.82 | 1.92 | 2.45 |
| Depreciation | 3.67 | 3.88 | 3.93 | 4.20 | 5.20 |
| Profit before tax | 1.13 | −5.93 | 6.86 | 12.70 | 5.98 |
| Tax % | 227.2% | −3.5% | 15.6% | 29.5% | 12.2% |
| Exceptional items | 0.02 | 0.06 | −0.05 | 0.00 | 0.00 |
| Net Profit | −1.46 | −5.75 | 5.81 | 9.00 | 5.26 |
| EPS (Rs) | −14.54 | −57.46 | 58.12 | 8.18 | 3.49 |
| Dividend payout % | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% |
| Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|
| Equity Capital | 1.01 | 1.01 | 1.01 | 11.02 | 15.15 |
| Reserves | 10.71 | 4.95 | 10.77 | 9.74 | 43.45 |
| Borrowings | 20.47 | 15.36 | 20.53 | 22.17 | 37.17 |
| Other Liabilities | 16.54 | 15.27 | 17.18 | 21.67 | 22.84 |
| Total Liabilities | 48.73 | 36.59 | 49.49 | 64.60 | 119 |
| Fixed Assets | 24.39 | 23.75 | 27.11 | 30.72 | 48.24 |
| CWIP | 0.74 | 0.00 | 3.59 | 8.93 | 10.15 |
| Investments | 5.27 | 0.10 | 0.20 | 0.22 | 16.92 |
| Other Assets | 18.33 | 12.74 | 18.59 | 24.73 | 43.30 |
| Inventories | 1.52 | 1.96 | 2.98 | 4.93 | 7.09 |
| Trade receivables | 8.99 | 8.05 | 10.34 | 12.75 | 15.77 |
| Cash & equivalents | 4.63 | 0.14 | 0.40 | 0.77 | 9.39 |
| Total Assets | 48.73 | 36.59 | 49.49 | 64.60 | 119 |
| Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|
| Cash from operating activity | 3.65 | −0.13 | 7.96 | 13.78 | 3.84 |
| Cash from investing activity | −5.21 | 2.12 | −11.04 | −13.16 | −40.34 |
| Cash from financing activity | 4.51 | −6.48 | 3.37 | −0.23 | 45.10 |
| Net cash flow | 2.95 | −4.49 | 0.27 | 0.38 | 8.63 |
| Capex | 5.21 | 3.32 | 11.00 | 13.12 | 22.58 |
| Free cash flow | −1.50 | −3.28 | −3.05 | 0.59 | −19.92 |
| CFO / OP % | 52.0% | 12.0% | 60.1% | 98.1% | 36.1% |
| Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|
| Debtor days | 54 | 51 | 55 | 59 | 68 |
| Inventory days | 27 | 42 | 62 | 96 | 121 |
| Days payable | 171 | 170 | 176 | 159 | 195 |
| Cash conversion cycle | −91 | −77 | −58 | −4 | −7 |
| Working capital days | −45 | −60 | −36 | −43 | −45 |
| ROCE % | — | −17.2% | 32.8% | 39.0% | 12.2% |
For the Mar 2026 quarter, Modern Diagnostic & Research Centre reported sales of ₹39.95 Cr and net profit of ₹2.09 Cr. The operating margin was 12.7%.
Modern Diagnostic & Research Centre's sales for the year to Mar 2026 were ₹83.18 Cr.
Net profit for the year to Mar 2026 was ₹5.26 Cr. Earnings per share over the same trailing period were ₹3.49.
Modern Diagnostic & Research Centre reported borrowings of ₹37.17 Cr at Mar 2026, against cash and equivalents of ₹9.39 Cr.
Cash from operations was ₹3.84 Cr in the year to Mar 2026; after capital spending, free cash flow was −₹19.92 Cr.